Marc Kozin is a Senior Advisor and former President of L.E.K. Consulting, a global management consulting firm. He is a career strategy consultant with 30 years of experience, both domestically and internationally, advising senior executives in life sciences to identify new growth opportunities, pursue highly-profitable mergers and acquisitions, and support sustained growth. He currently sits on the Boards of Endocyte, Inc., Flex Pharma, OvaScience and UFP Technologies in various capacities. Mr. Kozin also sits on the Boards of HealthCare Royalty and Helomics Corporation, both private companies. Additionally, Mr. Kozin has served on the Board of Governors at New England Medical Center for several years, and the Board of Directors for Dyax Corp., which acquired by Shire Plc for $5.9B in 2015. In 2002, Consulting Magazine named him one of the 25 most influential consultants in recognition of his leadership and results for clients. Mr. Kozin received a B.A. in Economics from Duke University and an MBA from The Wharton School, University of Pennsylvania.